This quality verification study examines Palonosetron 0.5mg from Nausea Long, focusing on analytical parameters and formulation quality. The investigation employs sophisticated analytical techniques to determine product purity, concentration accuracy, and overall pharmaceutical quality. Comprehensive testing was performed to ensure the product meets regulatory standards for antiemetic medications.

ELISA and MS: Enzyme-Linked Immunosorbent Assay (ELISA) provided sensitive detection and quantification, while Mass Spectrometry (MS) offered precise molecular identification and characterization of compounds.

The Palonosetron 0.5mg formulation shows outstanding quality with purity levels above 93%. Analytical results confirm appropriate concentration of the active ingredient with minimal impurities detected. The product demonstrates consistent quality suitable for clinical use in managing chemotherapy-induced nausea and vomiting.